Urine leucine-rich α-2 glycoprotein 1 (LRG1) predicts the risk of progression to end-stage kidney disease in patients with type 2 diabetes

Urine leucine-rich α-2 glycoprotein 1 (LRG1) predicts the risk of progression to end-stage kidney disease in patients with type 2 diabetes

OBJECTIVE: Leucine-rich a-2 glycoprotein 1 (LRG1) was recently identified as an amplifier of transforming growth factor-b (TGF-b)–induced kidney fibrosis in animal models. We aimed to study whether urine LRG1 is associated with risk of progression to end-stage kidney disease (ESKD) in individuals wi...

Full description

Bibliographic Details
Main Authors: Liu, Jian-Jun, Liu, Sylvia, Wang, Jiexun, Pek, Sharon L. T., Lee, Janus, Gurung, Resham L., Ang, Keven, Shao, Yi Ming, Tavintharan, Subramaniam, Tang, Wern Ee, Sum, Chee Fang, Lim, Su Chi
Other Authors: Lee Kong Chian School of Medicine (LKCMedicine)
Format: Journal Article
Language:English
Published: 2023
Subjects:
Science::Medicine
LRG1 Protein
End Stage Renal Disease
Online Access:https://hdl.handle.net/10356/172167

Similar Items

Similar Items